Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice

International Journal of Cancer

Volumn 77, Issue 2, 1998, Pages 257-263

  Lyu, Mi Ae ^a   Choi, Yang Kyu ^b   Park, Bo Na ^a   Park, Byung Joon ^c   Kim, Bum Joon ^a   Park, Il Kyoo ^a   Hyun, Byung Hwa ^b   Kook, Yoon Hoh ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CHORIOALLANTOIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; SQUAMOUS CELL CARCINOMA;

ALLANTOIS; ANIMALS; CARCINOMA, SQUAMOUS CELL; CHICK EMBRYO; CHORION; HUMANS; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031832235     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980717)77:2<257::AID-IJC15>3.0.CO;2-8     Document Type: Article

References (20)

1. ANDREASEN, P., GEORG, B., LUND, L.R., RICCIO, A. and STAGEY, S.N., Plasminogen activator inhibitors: hormenally regulated serpins. Mol. cell. Epdocrinol., 68, 1-19 (1990).
2. BIANCHI, E., COHEN, R.L., THOR, A.T., TODD, R.F., MIZUKAMI, I.F., LAWRENCE, D.A., LJUNG, B.M., SHUMAN, M.A. and SMITH, H.S., The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res., 54, 861-866 (1994).
3. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid-guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
4. ELLIS, V., SCULLY, M.F. and KAKKAR, V.V., Plasminogen activation initiated by single-chain urokinase-type plasminogen activator: potentiation by U937 cells. J. biol. Chem., 264, 2185-2188 (1989).
5. HOLLAS, W., BLASI, F. and BOYD, D., Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res., 51, 3690-3695 (1991).
6. KOBAYASHI, H., OHI, H., SHINOHARA, H., SUGIMURA, M., FUJII, T., TERAO, T., SCHMITT, M., GORETZKI, L., CHUCHOLOWSKI, N., JANICKE, F. and GRAEFF, H., Saturation of tumour-cell-surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement-membrane invasion. Brit. J. Cancer, 67, 537-544 (1993).
7. KOBAYASHI, H., OHI, H., SUGIMURA, M., SHINOHARA, H., FUJII, T. and TERAO, T., Inhibition of in vitro ovarian-cancer-cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res., 52, 3610-3614 (1992).
8. KOOK, Y.H., ADAMSKI, J., ZELENT, A. and OSSOWSKI, L., The effect of anti-sense inhibition of urokinase receptor in human squamous-cell carcinoma on malignancy. EMBO J., 13, 3983-3991 (1994).
9. LUND, L.R., ELLIS, V., RØNNE, E., PYKE, C. and DANØ, K., Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung-carcinoma cell line A549. Biochem. J., 310, 345-352 (1995).
10. MANDRIOTA, S.J., SEGHEZZI, G., VASSALLI, J.-D., FERRARA, N., WASI, S., MAZZIERI, R., MIGNATTI, P. and PEPPER, M.S., Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. biol. Chem., 270, 9709-9716 (1995).
11. MIN, H.Y., DOYLE, L.V., VITT, C.R., ZANDONELLA, C.L., STRATTON-THOMAS, J.R., SHUMAN, M.A. and ROSENBERG, S., Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res., 56, 2428-2433 (1996).
12. MOHANAM, S., SAWAYA, R., MCCUTCHEON, I., ALI-OSMAN, F., BOYD, D. and RAO, J.S., Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res., 53, 4143-4147 (1993).
13. PLOUG, M., RØNNE, E., BEHRENDT, N., JENSEN, A.L., BLASI, F. and DANØ, K., Cellular receptor for urokinase plasminogen activator: carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. biol. Chem., 266, 1926-1933 (1991).
14. PYKE, C., KRISTENSEN, P., RALFKIæR, E., GRØNDAHL-HANSEN, J., ERIKSEN, J., BLASI, F. and DANØ, K., Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Amer. J. Pathol., 138, 1059-1067 (1991).
15. ROLDAN, A.L., CUBELLIS, M.V., MASUCCI, M.T., BEHRENDT, N., LUND, L.R., DANØ, K., APPELLA, E. and BLASI, F., Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell-surface, plasmin-dependent proteolysis. EMBO J., 9, 467-474 (1990).
16. SHETTY, S., KUMAR, A. and IDELL, S., Post-transcriptional regulation of urokinase-receptor mRNA: identification of a novel urokinase-receptor-mRNA-binding protein in human mesothelioma cells. Mol. cell. Biol., 17, 1075-1083 (1997).
17. SAS, Statistical Analysis System software, v. 6.12. SAS Institute Inc., Cary, NC (1989-1996).
18. STETLER-STEVENSON, W.G., LIOTTA, L.A. and KLEINER, D.E., Extracellular matrix 6: role of matrix metalloproteases in tumor invasion and metastasis. FASEB J., 7, 1434-1441 (1993).
19. TSUBOI, R. and RIFKIN, D.B., Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity. Int. J. Cancer, 46, 56-60 (1990).
20. r 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol., 100, 86-92 (1985).